Related Experiment Video
Updated: Sep 9, 2026
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Psychometric Evaluation of the Dimensional Anhedonia Rating Scale (DARS): A Preliminary Study
Parker Grant1,2, Marcos Sanches1,3, Tony P George2
1Institute of Medical Sciences and Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto.
Aim:
Anhedonia is a transdiagnostic symptom of major depressive disorder (MDD) that is also influenced by substance use, yet the Dimensional Anhedonia Rating Scale (DARS) has only been validated in MDD. This study examined the psychometric properties of the DARS in co-occurring MDD and cannabis use disorder (CUD).
Methods:
Thirty-five participants completed the DARS, Snaith-Hamilton Pleasure Scale (SHAPS), Hamilton Rating Scale for Depression (HRSD), Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI). Analyses included confirmatory factor analysis, internal consistency, Spearman correlations, group comparisons, and ROC analysis against SHAPS-defined anhedonia.
Results:
The DARS supported a four-factor (and second-order) structure, demonstrated excellent internal consistency, and showed expected convergent validity (e.g., SHAPS ρ=-.64). ROC analysis indicated good discrimination (AUC=.81) with a Youden-derived threshold of 65 (sensitivity ≈.85; specificity ≈.75).
Conclusions:
This study provides preliminary evidence of the utility of the DARS in co-occurring MDD and CUD.
